1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34.
https://doi.org/10.3322/caac.21590
https://doi.org/10.3322/caac.21442
https://doi.org/10.3322/caac.21551
https://doi.org/10.3322/caac.21332 [
DOI:10.3322/caac.21387]
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [
DOI:10.3322/caac.21492] [
PMID]
3. Liu SA, Wong YK, Lin JC, Poon CK, Tung KC, Tsai WC. Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse. Otolaryngol Head Neck Surg. 2007;136(1):112-8. [
DOI:10.1016/j.otohns.2006.07.002] [
PMID]
4. Sharma P, Saxena S, Aggarwal P. Trends in the epidemiology of oral squamous cell carcinoma in Western UP: an institutional study. Indian J Dent Res. 2010;21(3):316-9. [
DOI:10.4103/0970-9290.70782] [
PMID]
5. Woolgar JA, Scott J, Vaughan E, Brown J, West C, Rogers S. Survival, metastasis and recurrence of oral cancer in relation to pathological features. Annals of the Royal College of Surgeons of England. 1995;77(5):325.
6. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 2008;10(2):R25. [
DOI:10.1186/bcr1982] [
PMID] [
PMCID]
7. Islam F, Qiao B, Smith RA, Gopalan V, Lam AK-Y. Cancer stem cell: fundamental experimental pathological concepts and updates. Exp Mol Pathol. 2015;98(2):184-91. [
DOI:10.1016/j.yexmp.2015.02.002] [
PMID]
8. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004;23(43):7274-82. [
DOI:10.1038/sj.onc.1207947] [
PMID]
9. Allegra A, Alonci A, Penna G, Innao V, Gerace D, Rotondo F, et al. The cancer stem cell hypothesis: a guide to potential molecular targets. Cancer Invest. 2014;32(9):470-95. [
DOI:10.3109/07357907.2014.958231] [
PMID]
10. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. nature. 2001;414(6859):105-11. [
DOI:10.1038/35102167] [
PMID]
11. Yu CC, Hu FW, Yu CH, Chou MY. Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells. Head & neck. 2016;38(S1):E231-E8. [
DOI:10.1002/hed.23975] [
PMID]
12. Krishnamurthy S, Nor J. Head and neck cancer stem cells. Journal List. 2012;91(4):334-340. [
DOI:10.1177/0022034511423393] [
PMID] [
PMCID]
13. Vaiphei K, Sinha SK, Kochhar R. Comparative analysis of Oct4 in different histological subtypes of esophageal squamous cell carcinomas in different clinical conditions. Asian Pac J Cancer Prev. 2014;15(8):3519-24. [
DOI:10.7314/APJCP.2014.15.8.3519] [
PMID]
14. Li Y, Lv Z, He G, Wang J, Zhang X, Lu G, et al. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer. Oncotarget. 2015;6(11):9099-112. [
DOI:10.18632/oncotarget.3603] [
PMID] [
PMCID]
15. Ren ZH, Zhang CP, Ji T. Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasis. Oncol lett. 2016;11(3):1973-1979. [
DOI:10.3892/ol.2016.4207] [
PMID] [
PMCID]
16. Fu TY, Hsieh IC, Cheng JT, Tsai MH, Hou YY, Lee JH, et al. Association of OCT 4, SOX 2, and NANOG expression with oral squamous cell carcinoma progression. J Oral Pathol Med. 2016;45(2):89-95. [
DOI:10.1111/jop.12335] [
PMID]
17. Baghai Naini F, Aminishakib P, Abdollahi A, Hodjat M, Mohammadpour H, Kardouni Khoozestani N. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non-Tumor Tissue. Asian Pac J Cancer Prev. 2019;20(6):1649-1654. [
DOI:10.31557/APJCP.2019.20.6.1649] [
PMID] [
PMCID]
18. Mohtasham N, Ayatollahi H, Saghravanian N, Zare R, Shakeri M, Sahebkar A, et al. Evaluation of Tissue and Serum Expression Levels of Lactate Dehydrogenase Isoenzymes in Patients with Head and Neck Squamous Cell Carcinoma. Anticancer Agents Med Chem. 2019;19(17):2072-2078. [
DOI:10.2174/1871520619666191014160818] [
PMID]
19. Mohajertehran F, Ayatollahi H, Jafarian AH, Khazaeni K, Soukhtanloo M, Shakeri M-T, et al. Overexpression of Lactate Dehydrogenase in the Saliva and Tissues of Patients with Head and Neck Squamous Cell Carcinoma. Rep Biochem Mol Biol. 2019;7(2):142-149.
20. Griffin JD, Lowenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood. 1986;68(6):1185-95.
https://doi.org/10.1182/blood.V68.6.1185.1185 [
DOI:10.1182/blood.V68.6.1185.bloodjournal6861185]
21. Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 2009;11(4):R46. [
DOI:10.1186/bcr2333] [
PMID] [
PMCID]
22. Hussenet T, du Manoir S. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis. Cell Cycle. 2010;9(8):1480-6. [
DOI:10.4161/cc.9.8.11203] [
PMID]
23. Verma V, Chandrashekar C. Evaluation of SOX2 and podoplanin expression in oral epithelial dysplasia and its correlation with malignant transformation. Journal of investigative and clinical dentistry. 2019;10(4):e12450. [
DOI:10.1111/jicd.12450]
24. Qiao B, He B, Cai J, Yang W. The expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa. Int J Clin Exp Pathol. 2014;7(1):28-37.
25. Yuan P, Kadara H, Behrens C, Tang X, Woods D, Solis LM, et al. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PloS one. 2010;5(2):e9112. [
DOI:10.1371/journal.pone.0009112] [
PMID] [
PMCID]
26. de Vicente JC, Donate-Pérez del Molino P, Rodrigo JP, Allonca E, Hermida-Prado F, Granda-Díaz R, et al. SOX2 Expression Is an Independent Predictor of Oral Cancer Progression. J Clin Med. 2019;8(10):1744. [
DOI:10.3390/jcm8101744] [
PMID] [
PMCID]
27. Huang CF, Xu XR, Wu TF, Sun ZJ, Zhang WF. Correlation of ALDH 1, CD 44, OCT 4 and SOX 2 in tongue squamous cell carcinoma and their association with disease progression and prognosis. J Oral Pathol Med. 2014;43(7):492-8. [
DOI:10.1111/jop.12159] [
PMID]
28. González-Márquez R, Llorente JL, Rodrigo JP, García-Pedrero JM, Álvarez-Marcos C, Suárez C, et al. SOX2 expression in hypopharyngeal, laryngeal, and sinonasal squamous cell carcinoma. Human pathology. 2014;45(4):851-7. [
DOI:10.1016/j.humpath.2013.12.004] [
PMID]
29. Neumann J, Bahr F, Horst D, Kriegl L, Engel J, Mejías-Luque R, et al. SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC cancer. 2011;11:518. [
DOI:10.1186/1471-2407-11-518] [
PMID] [
PMCID]
30. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature. 2006;444(7117):364-8. [
DOI:10.1038/nature05284] [
PMID]
31. Park I-H, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. nature. 2008;451(7175):141-6. [
DOI:10.1038/nature06534] [
PMID]
32. Tsai L-L, Hu F-W, Lee S-S, Yu C-H, Yu C-C, Chang Y-C. Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition. PloS one. 2014;9(1):e87207. [
DOI:10.1371/journal.pone.0087207] [
PMID] [
PMCID]